BPTF is essential for T cell homeostasis and function

Journal of Immunology

Volumn 197, Issue 11, 2016, Pages 4325-4333

  Wu, Bing ^a   Wang, Yunqi ^a   Wang, Chaojun ^a,b   Wang, Gang Greg ^a   Wu, Jie ^b   Wan, Yisong Y ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BROMODOMAIN PHD FINGER TRANSCRIPTION FACTOR; CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 17; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG; CELL NUCLEUS ANTIGEN; FETAL ALZHEIMER ANTIGEN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE; NERVE PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COUNT; CELL SPECIFICITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FLOW CYTOMETRY; GENE DELETION; IMMUNOREGULATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; THYMUS; ANIMAL; AUTOIMMUNE DISEASE; GENE EXPRESSION REGULATION; GENETICS; HOMEOSTASIS; IMMUNOLOGY; KNOCKOUT MOUSE; PATHOLOGY; SYNDROME;

ANIMALS; ANTIGENS, NUCLEAR; AUTOIMMUNE DISEASES; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; HOMEOSTASIS; MICE; MICE, KNOCKOUT; NERVE TISSUE PROTEINS; SYNDROME; T-LYMPHOCYTES, REGULATORY; TRANSCRIPTION FACTORS;

EID: 84996503574     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1600642     Document Type: Article

References (50)

1. Smeenk, G., and H. van Attikum. 2013. The chromatin response to DNA breaks: leaving a mark on genome integrity. Annu. Rev. Biochem. 82: 55-80.
2. Venkatesh, S., and J. L. Workman. 2015. Histone exchange, chromatin structure and the regulation of transcription. Nat. Rev. Mol. Cell Biol. 16: 178-189.
3. Bannister, A. J., and T. Kouzarides. 2011. Regulation of chromatin by histone modifications. Cell Res. 21: 381-395.
4. Papamichos-Chronakis, M., and C. L. Peterson. 2013. Chromatin and the ge-nome integrity network. Nat. Rev. Genet. 14: 62-75.
5. Ransom, M., B. K. Dennehey, and J. K. Tyler. 2010. Chaperoning histones during DNA replication and repair. Cell 140: 183-195.
6. Chan, Y. A., P. Hieter, and P. C. Stirling. 2014. Mechanisms of genome insta-bility induced by RNA-processing defects. Trends Genet. 30: 245-253.
7. Wang, G. G., C. D. Allis, and P. Chi. 2007. Chromatin remodeling and cancer, Part II: ATP-dependent chromatin remodeling. Trends Mol. Med. 13: 373-380.
8. Mehrotra, A., G. Mehta, S. Aras, A. Trivedi, and I. L. de la Serna. 2014. SWI/SNF chromatin remodeling enzymes in melanocyte differentiation and mela-noma. Crit. Rev. Eukaryot. Gene Expr. 24: 151-161.
9. Dai, M., J. J. Lu, W. Guo, W. Yu, Q. Wang, R. Tang, Z. Tang, Y. Xiao, Z. Li, W. Sun, et al. 2015. BPTF promotes tumor growth and predicts poor prognosis in lung adenocarcinomas. Oncotarget 6: 33878-33892.
10. Rajendrasozhan, S., H. Yao, and I. Rahman. 2009. Current perspectives on role of chromatin modifications and deacetylases in lung inflammation in COPD. COPD 6: 291-297.
11. Hohmann, A. F., and C. R. Vakoc. 2014. A rationale to target the SWI/SNF complex for cancer therapy. Trends Genet. 30: 356-363.
12. Mayes, K., Z. Qiu, A. Alhazmi, and J. W. Landry. 2014. ATP-dependent chro-matin remodeling complexes as novel targets for cancer therapy. Adv. Cancer Res. 121: 183-233.
13. Biegel, J. A., T. M. Busse, and B. E. Weissman. 2014. SWI/SNF chromatin remodeling complexes and cancer. Am. J. Med. Genet. C. Semin. Med. Genet. 166C: 350-366.
14. Bevan, M. J. 2004. Helping the CD8(+) T-cell response. Nat. Rev. Immunol. 4: 595-602.
15. Gajewski, T. F., H. Schreiber, and Y. X. Fu. 2013. Innate and adaptive immune cells in the tumor microenvironment. Nat. Immunol. 14: 1014-1022.
16. Kaech, S. M., E. J. Wherry, and R. Ahmed. 2002. Effector and memory T-cell differentiation: implications for vaccine development. Nat. Rev. Immunol. 2: 251-262.
17. Callard, R. E. 2007. Decision-making by the immune response. Immunol. Cell Biol. 85: 300-305.
18. Beyer, M., and J. L. Schultze. 2006. Regulatory T cells in cancer. Blood 108: 804-811.
19. Chaiyachati, B. H., A. Jani, Y. Wan, H. Huang, R. Flavell, and T. Chi. 2013. BRG1-mediated immune tolerance: facilitation of Treg activation and partial independence of chromatin remodelling. EMBO J. 32: 395-408.
20. Thomas, R. M., L. Gao, and A. D. Wells. 2005. Signals from CD28 induce stable epigenetic modification of the IL-2 promoter. J. Immunol. 174: 4639-4646.
21. Chi, T. H., M. Wan, P. P. Lee, K. Akashi, D. Metzger, P. Chambon, C. B. Wilson, and G. R. Crabtree. 2003. Sequential roles of Brg, the ATPase subunit of BAF chromatin remodeling complexes, in thymocyte development. Immunity 19: 169-182.
22. Chi, T. H., M. Wan, K. Zhao, I. Taniuchi, L. Chen, D. R. Littman, and G. R. Crabtree. 2002. Reciprocal regulation of CD4/CD8 expression by SWI/SNF-like BAF complexes. Nature 418: 195-199.
23. Jani, A., M. Wan, J. Zhang, K. Cui, J. Wu, P. Preston-Hurlburt, R. Khatri, K. Zhao, and T. Chi. 2008. A novel genetic strategy reveals unexpected roles of the Swi-Snf-like chromatin-remodeling BAF complex in thymocyte develop-ment. J. Exp. Med. 205: 2813-2825.
24. Wurster, A. L., and M. J. Pazin. 2008. BRG1-mediated chromatin remodeling regulates differentiation and gene expression of T helper cells. Mol. Cell. Biol. 28: 7274-7285.
25. Li, H., S. Ilin, W. Wang, E. M. Duncan, J. Wysocka, C. D. Allis, and D. J. Patel. 2006. Molecular basis for site-specific read-out of histone H3K4me3 by the BPTF PHD finger of NURF. Nature 442: 91-95.
26. Ruthenburg, A. J., H. Li, T. A. Milne, S. Dewell, R. K. McGinty, M. Yuen, B. Ueberheide, Y. Dou, T. W. Muir, D. J. Patel, and C. D. Allis. 2011. Recog-nition of a mononucleosomal histone modification pattern by BPTF via multi-valent interactions. Cell 145: 692-706.
27. Landry, J. W., S. Banerjee, B. Taylor, P. D. Aplan, A. Singer, and C. Wu. 2011. Chromatin remodeling complex NURF regulates thymocyte maturation. Genes Dev. 25: 275-286.
28. Landry, J., A. A. Sharov, Y. Piao, L. V. Sharova, H. Xiao, E. Southon, J. Matta, L. Tessarollo, Y. E. Zhang, M. S. Ko, et al. 2008. Essential role of chromatin remodeling protein Bptf in early mouse embryos and embryonic stem cells. PLoS Genet. 4: e1000241.
29. Lee, P. P., D. R. Fitzpatrick, C. Beard, H. K. Jessup, S. Lehar, K. W. Makar, M. Pérez-Melgosa, M. T. Sweetser, M. S. Schlissel, S. Nguyen, et al. 2001. A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival. Immunity 15: 763-774.
30. Moulton, V. R., and G. C. Tsokos. 2015. T cell signaling abnormalities con-tribute to aberrant immune cell function and autoimmunity. J. Clin. Invest. 125: 2220-2227.
31. Zhou, X., L. T. Jeker, B. T. Fife, S. Zhu, M. S. Anderson, M. T. McManus, and J. A. Bluestone. 2008. Selective miRNA disruption in T reg cells leads to uncontrolled autoimmunity. J. Exp. Med. 205: 1983-1991.
32. Komatsu, N., K. Okamoto, S. Sawa, T. Nakashima, M. Oh-hora, T. Kodama, S. Tanaka, J. A. Bluestone, and H. Takayanagi. 2014. Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis. Nat. Med. 20: 62-68.
33. Schmidt, A., N. Oberle, and P. H. Krammer. 2012. Molecular mechanisms of treg-mediated T cell suppression. Front. Immunol. 3: 51.
34. Abdolahi, M., P. Yavari, N. M. Honarvar, S. Bitarafan, M. Mahmoudi, and A. A. Saboor-Yaraghi. 2015. Molecular mechanisms of the action of vitamin A in Th17/Treg axis in multiple sclerosis. J. Mol. Neurosci. 57: 605-613.
35. Leavy, O. 2014. Regulatory T cells: going over to the dark side. Nat. Rev. Immunol. 14: 5.
36. Sakaguchi, S., D. A. Vignali, A. Y. Rudensky, R. E. Niec, and H. Waldmann. 2013. The plasticity and stability of regulatory T cells. Nat. Rev. Immunol. 13: 461-467.
37. Hori, S. 2014. Lineage stability and phenotypic plasticity of Foxp3? regulatory T cells. Immunol. Rev. 259: 159-172.
38. Bailey-Bucktrout, S. L., M. Martinez-Llordella, X. Zhou, B. Anthony, W. Rosenthal, H. Luche, H. J. Fehling, and J. A. Bluestone. 2013. Self-antigen-driven activation induces instability of regulatory T cells during an inflammatory autoimmune response. Immunity 39: 949-962.
39. Zhou, X., S. L. Bailey-Bucktrout, L. T. Jeker, C. Penaranda, M. Martínez-Llordella, M. Ashby, M. Nakayama, W. Rosenthal, and J. A. Bluestone. 2009. Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat. Immunol. 10: 1000-1007.
40. Depis, F., H. K. Kwon, D. Mathis, and C. Benoist. 2016. Unstable FoxP3+ T regulatory cells in NZW mice. Proc. Natl. Acad. Sci. USA 113: 1345-1350.
41. Lal, G., and J. S. Bromberg. 2009. Epigenetic mechanisms of regulation of Foxp3 expression. Blood 114: 3727-3735.
42. Feng, Y., J. van der Veeken, M. Shugay, E. V. Putintseva, H. U. Osmanbeyoglu, S. Dikiy, B. E. Hoyos, B. Moltedo, S. Hemmers, P. Treuting, et al. 2015. A mechanism for expansion of regulatory T-cell repertoire and its role in self-tolerance. Nature 528: 132-136.
43. Wysocka, J., T. Swigut, H. Xiao, T. A. Milne, S. Y. Kwon, J. Landry, M. Kauer, A. J. Tackett, B. T. Chait, P. Badenhorst, et al. 2006. A PHD finger of NURF couples histone H3 lysine 4 trimethylation with chromatin remodelling. Nature 442: 86-90.
44. Jeong, S. M., C. Lee, S. K. Lee, J. Kim, and R. H. Seong. 2010. The SWI/SNF chromatin-remodeling complex modulates peripheral T cell activation and proliferation by controlling AP-1 expression. J. Biol. Chem. 285: 2340-2350.
45. Clapier, C. R., and B. R. Cairns. 2009. The biology of chromatin remodeling complexes. Annu. Rev. Biochem. 78: 273-304.
46. Richart, L., E. Carrillo-de Santa Pau, A. Río-Machin, M. P. de Andrés, J. C. Cigudosa, V. J. Lobo, and F. X. Real. 2016. BPTF is required for c-MYC transcriptional activity and in vivo tumorigenesis. Nat. Commun. 7: 10153.
47. Dar, A. A., M. Nosrati, V. Bezrookove, D. de Semir, S. Majid, S. Thummala, V. Sun, S. Tong, S. P. L. Leong, D. Minor, et al. 2015. The role of BPTF in melanoma progression and in response to BRAF-targeted therapy. J. Natl. Cancer Inst. DOI: 10.1093/jnci/djv034.
48. Haxhinasto, S., D. Mathis, and C. Benoist. 2008. The AKT-mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells. J. Exp. Med. 205: 565-574.
49. Douglas, N. C., H. Jacobs, A. L. Bothwell, and A. C. Hayday. 2001. Defining the specific physiological requirements for c-Myc in T cell development. Nat. Immunol. 2: 307-315.
50. Chou, C., A. K. Pinto, J. D. Curtis, S. P. Persaud, M. Cella, C. C. Lin, B. T. Edelson, P. M. Allen, M. Colonna, E. L. Pearce, et al. 2014. c-Myc-induced transcription factor AP4 is required for host protection mediated by CD8+ T cells. Nat. Immunol. 15: 884-893.